What is PathologyWatch?

Dr. Larson received her medical degree from the University of Utah and completed a research fellowship at the Tom C. Mathews Familial Melanoma Research Clinic at Huntsman Cancer Institute. After her dermatology residency at Dartmouth-Hitchcock Medical Center, she devoted herself to patient care for over 10 years. Through PathologyWatch, she sees digital pathology as key to improving dermatology diagnostics through the enhanced correlation of microscopic and clinical skin findings. As the director of the clinical advisory board and clinical implementation at PathologyWatch, she is focused on advancing patient care and access by delivering digital pathology and artificial intelligence solutions to dermatologists both nationally and globally.

Michael Torno has a BA from Kent State and an MA from the University of Akron in Organizational Psychology. Prior to co-founding PathologyWatch, he served as the Senior Vice President of global clinical healthcare markets at Ascend Learning (a portfolio company of Blackstone Private Equity) as well as the general manager of NursingCE. Mr. Torno spent the early stages of his career at Arthur Andersen. In 2002, he immersed himself in the healthcare sector and joined Cerner Corporation and relocated to Australia to drive Cerner’s global expansion. Upon completion of his expatriate assignment, Mr. Torno became a partner in an infectious disease laboratory (Viracor Labs).

Nicky Crawford has over 23 years of management and venture capital experience, including a successful tenure with Dan Lambert at BoardVitals. A core member from the early stages of PathologyWatch, she builds out and manages successful teams, including QA/QC, HR, contracting/credentialing, logistics, and accounts payable/receivable.

Dr. Hester obtained his PhD in chemistry from the University of Cincinnati, focusing on innovative synthetic approaches to modify nucleic acids and their application in molecular diagnostics. He completed his postgraduate training in applied molecular biology through the Oak Ridge National Laboratory Research Fellowship Program. With over 25 years of experience, Dr. Hester has held key positions such as VP of research and development, executive director of laboratory operations, and director of molecular diagnostics at renowned clinical laboratories and contract research organizations (CROs). He has authored numerous peer-reviewed scientific articles and holds multiple patents for molecular diagnostic methods. Dr. Hester has also served as an adjunct assistant professor and assistant professor in the Department of Pathology and Laboratory Medicine at the University of Kansas School of Medicine.